Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	RAPGEF6 NET1 MYCBP2 ARHGEF11 DOCK5 VAV3 DOCK1 ARHGEF2 FGD6 RAPGEFL1 SOS1	2.34e-05	231	201	11	GO:0005085
GeneOntologyMolecularFunction	adenylosuccinate synthase activity	ADSS2 ADSS1	1.01e-04	2	201	2	GO:0004019
GeneOntologyCellularComponent	sarcolemma	DYSF DST PLEC FER1L5 UTRN COL6A3 REM1 MYOT AQP4 SLC8A3 ATP1A3 AHNAK2	3.45e-07	190	202	12	GO:0042383
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO2 NOMO1 NOMO3	7.15e-05	9	202	3	GO:0160064
GeneOntologyCellularComponent	integrin alpha4-beta7 complex	ITGA4 ITGB7	9.29e-05	2	202	2	GO:0034669
GeneOntologyCellularComponent	centrosome	MKKS RAPGEF6 CCDC18 CEP76 STOX1 DYSF USP20 IVL CCDC112 HSF1 DYNC1H1 CEP290 OBSL1 CCDC141 SLC1A4 TRIM32 CAPN7 HASPIN PATJ	1.81e-04	770	202	19	GO:0005813
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO2 NOMO1 NOMO3	2.99e-04	14	202	3	GO:0072379
GeneOntologyCellularComponent	supramolecular fiber	DYSF PARP4 DST MYPN PLEC DNAH5 DYNC1H1 COL6A3 SHROOM3 REM1 MYOT DSP DYNC2H1 MYOM3 KCNAB2 OBSL1 LCP1 SHROOM2 SLC1A4 SLC8A3 TRIM32 EHHADH ARHGEF2 AHNAK2	4.59e-04	1179	202	24	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	DYSF PARP4 DST MYPN PLEC DNAH5 DYNC1H1 COL6A3 SHROOM3 REM1 MYOT DSP DYNC2H1 MYOM3 KCNAB2 OBSL1 LCP1 SHROOM2 SLC1A4 SLC8A3 TRIM32 EHHADH ARHGEF2 AHNAK2	5.06e-04	1187	202	24	GO:0099081
GeneOntologyCellularComponent	sarcomere	DST MYPN PLEC REM1 MYOT MYOM3 OBSL1 TRIM32 AHNAK2	7.35e-04	249	202	9	GO:0030017
GeneOntologyCellularComponent	sarcoplasm	MB SRL PLEC XDH SLC8A3 P3H2	8.49e-04	114	202	6	GO:0016528
GeneOntologyCellularComponent	subapical complex	MPDZ PATJ	9.12e-04	5	202	2	GO:0035003
GeneOntologyCellularComponent	T-tubule	DYSF FER1L5 REM1 AQP4 AHNAK2	1.01e-03	79	202	5	GO:0030315
GeneOntologyCellularComponent	I band	DST MYPN PLEC REM1 MYOT OBSL1 AHNAK2	1.18e-03	166	202	7	GO:0031674
GeneOntologyCellularComponent	myofibril	DST MYPN PLEC REM1 MYOT MYOM3 OBSL1 TRIM32 AHNAK2	1.40e-03	273	202	9	GO:0030016
GeneOntologyCellularComponent	microtubule organizing center	MKKS RAPGEF6 CCDC18 CEP76 STOX1 DYSF USP20 IVL CCDC112 HSF1 DYNC1H1 CEP290 OBSL1 CCDC141 SLC1A4 TRIM32 CAPN7 HASPIN PATJ	1.53e-03	919	202	19	GO:0005815
HumanPheno	Quadriceps muscle weakness	DYSF PHKA1 VCP ADSS1 COL6A3 GNE TRIM32	3.62e-08	23	80	7	HP:0003731
HumanPheno	Pelvic girdle muscle weakness	DYSF PHKA1 PLEC VCP COL6A3 MYOT GNE TRIM32	9.57e-07	51	80	8	HP:0003749
HumanPheno	Abnormal morphology of the pelvis musculature	DYSF PHKA1 PLEC VCP COL6A3 MYOT GNE TRIM32	1.12e-06	52	80	8	HP:0001469
HumanPheno	Abnormality of the hip-girdle musculature	DYSF PHKA1 PLEC VCP COL6A3 MYOT GNE TRIM32	1.12e-06	52	80	8	HP:0001445
HumanPheno	Progressive proximal muscle weakness	DYSF PLEC VCP COL6A3 MYOT	5.19e-05	27	80	5	HP:0009073
HumanPheno	Increased variability in muscle fiber diameter	MB DYSF MYPN PLEC VCP COL6A3 MYOT GNE TRIM32	7.21e-05	116	80	9	HP:0003557
HumanPheno	Abnormality of skeletal muscle fiber size	MB DYSF MYPN PLEC VCP COL6A3 MYOT GNE TRIM32	1.00e-04	121	80	9	HP:0012084
HumanPheno	Increased circulating purine concentration	SPTA1 SPTB SARS2 MOCOS XDH EHHADH	1.01e-04	49	80	6	HP:0004368
HumanPheno	Limb muscle weakness	MB DYSF PHKA1 KARS1 PI4KA MYPN PLEC DYNC1H1 VCP ADSS1 HSPD1 COL6A3 MYOT GNE TRIM32 GAN	1.10e-04	359	80	16	HP:0003690
HumanPheno	Limited knee flexion/extension	DYSF VCP MYOT	1.25e-04	7	80	3	HP:0005085
HumanPheno	Limited knee flexion	DYSF VCP MYOT	1.25e-04	7	80	3	HP:0006389
HumanPheno	Proximal muscle weakness in lower limbs	MB DYSF PHKA1 KARS1 DYNC1H1 VCP ADSS1 COL6A3 MYOT GNE TRIM32	1.33e-04	186	80	11	HP:0008994
HumanPheno	Abnormality of the musculature of the lower limbs	MB DYSF PHKA1 KARS1 PI4KA PLEC DYNC1H1 VCP ADSS1 COL6A3 MYOT RARS1 GNE TRIM32	1.76e-04	297	80	14	HP:0001437
HumanPheno	Limb-girdle muscle weakness	DYSF PHKA1 PLEC VCP COL6A3 MYOT GNE TRIM32	1.85e-04	103	80	8	HP:0003325
HumanPheno	Proximal muscle weakness	MB DYSF PHKA1 KARS1 MYPN PLEC DYNC1H1 VCP ADSS1 COL6A3 MYOT GNE PREPL TRIM32 GAN	2.09e-04	340	80	15	HP:0003701
HumanPheno	Abnormal circulating purine concentration	SPTA1 SPTB SARS2 MOCOS XDH EHHADH	2.16e-04	56	80	6	HP:0004352
HumanPheno	Shoulder girdle muscle weakness	DYSF VCP COL6A3 MYOT GNE TRIM32	2.38e-04	57	80	6	HP:0003547
HumanPheno	Pyropoikilocytosis	SPTA1 SPTB	2.44e-04	2	80	2	HP:0004839
HumanPheno	Hyporeflexia of lower limbs	DYSF DYNC1H1 ADSS1 MYOT GAN	2.82e-04	38	80	5	HP:0002600
Domain	Spectrin_repeat	SPTA1 SPTB DST PLEC UTRN DSP CCDC141	1.79e-08	29	199	7	IPR002017
Domain	SPEC	SPTA1 SPTB DST PLEC UTRN DSP	9.76e-07	32	199	6	SM00150
Domain	Spectrin/alpha-actinin	SPTA1 SPTB DST PLEC UTRN DSP	9.76e-07	32	199	6	IPR018159
Domain	Spectrin	SPTA1 SPTB DST UTRN CCDC141	3.76e-06	23	199	5	PF00435
Domain	ACTININ_2	SPTB DST PLEC UTRN LCP1	3.76e-06	23	199	5	PS00020
Domain	ACTININ_1	SPTB DST PLEC UTRN LCP1	3.76e-06	23	199	5	PS00019
Domain	Actinin_actin-bd_CS	SPTB DST PLEC UTRN LCP1	3.76e-06	23	199	5	IPR001589
Domain	DUF2012	NOMO2 NOMO1 NOMO3	4.73e-06	4	199	3	PF09430
Domain	DUF2012	NOMO2 NOMO1 NOMO3	4.73e-06	4	199	3	IPR019008
Domain	-	DST PLEC DSP	2.33e-05	6	199	3	3.90.1290.10
Domain	Plectin	DST PLEC DSP	4.04e-05	7	199	3	PF00681
Domain	Plectin_repeat	DST PLEC DSP	4.04e-05	7	199	3	IPR001101
Domain	PLEC	DST PLEC DSP	4.04e-05	7	199	3	SM00250
Domain	GDS_CDC24_CS	NET1 ARHGEF11 VAV3 ARHGEF2 SOS1	5.60e-05	39	199	5	IPR001331
Domain	DHC_N1	DNAH5 DYNC1H1 DYNC2H1	6.41e-05	8	199	3	PF08385
Domain	Carb-bd-like_fold	NOMO2 NOMO1 NOMO3	6.41e-05	8	199	3	IPR013784
Domain	Dynein_heavy_dom-1	DNAH5 DYNC1H1 DYNC2H1	6.41e-05	8	199	3	IPR013594
Domain	CH	SPTB DST VAV3 PLEC UTRN LCP1	6.64e-05	65	199	6	SM00033
Domain	RhoGEF	NET1 ARHGEF11 VAV3 ARHGEF2 FGD6 SOS1	8.58e-05	68	199	6	SM00325
Domain	RhoGEF	NET1 ARHGEF11 VAV3 ARHGEF2 FGD6 SOS1	1.01e-04	70	199	6	PF00621
Domain	CH	SPTB DST VAV3 PLEC UTRN LCP1	1.01e-04	70	199	6	PF00307
Domain	DH_2	NET1 ARHGEF11 VAV3 ARHGEF2 FGD6 SOS1	1.01e-04	70	199	6	PS50010
Domain	-	NET1 ARHGEF11 VAV3 ARHGEF2 FGD6 SOS1	1.09e-04	71	199	6	1.20.900.10
Domain	DH-domain	NET1 ARHGEF11 VAV3 ARHGEF2 FGD6 SOS1	1.09e-04	71	199	6	IPR000219
Domain	-	SPTB DST VAV3 PLEC UTRN LCP1	1.09e-04	71	199	6	1.10.418.10
Domain	Adenylsucc_synt	ADSS2 ADSS1	1.13e-04	2	199	2	SM00788
Domain	L27_2	MPDZ PATJ	1.13e-04	2	199	2	PF09045
Domain	ADENYLOSUCCIN_SYN_2	ADSS2 ADSS1	1.13e-04	2	199	2	PS00513
Domain	Adenylosuccin_syn_GTP-bd	ADSS2 ADSS1	1.13e-04	2	199	2	IPR018220
Domain	Adenylsucc_synt	ADSS2 ADSS1	1.13e-04	2	199	2	PF00709
Domain	Adenylosuccin_syn_Lys_AS	ADSS2 ADSS1	1.13e-04	2	199	2	IPR033128
Domain	L27_2	MPDZ PATJ	1.13e-04	2	199	2	IPR015132
Domain	Adenylosuccinate_synthetase	ADSS2 ADSS1	1.13e-04	2	199	2	IPR001114
Domain	ADENYLOSUCCIN_SYN_1	ADSS2 ADSS1	1.13e-04	2	199	2	PS01266
Domain	CH	SPTB DST VAV3 PLEC UTRN LCP1	1.28e-04	73	199	6	PS50021
Domain	PDZ	RAPGEF6 MPDZ ARHGEF11 SHROOM3 SHROOM2 SHANK3 PATJ AHNAK2	1.36e-04	141	199	8	PF00595
Domain	-	ITGB7 PARP4 INTS14 COL6A3 ITIH5 ANTXRL	1.38e-04	74	199	6	3.40.50.410
Domain	CH-domain	SPTB DST VAV3 PLEC UTRN LCP1	1.48e-04	75	199	6	IPR001715
Domain	PDZ	RAPGEF6 MPDZ ARHGEF11 SHROOM3 SHROOM2 SHANK3 PATJ AHNAK2	1.90e-04	148	199	8	SM00228
Domain	-	RAPGEF6 MPDZ ARHGEF11 SHROOM3 SHROOM2 SHANK3 PATJ AHNAK2	2.09e-04	150	199	8	2.30.42.10
Domain	PDZ	RAPGEF6 MPDZ ARHGEF11 SHROOM3 SHROOM2 SHANK3 PATJ AHNAK2	2.18e-04	151	199	8	PS50106
Domain	PDZ	RAPGEF6 MPDZ ARHGEF11 SHROOM3 SHROOM2 SHANK3 PATJ AHNAK2	2.28e-04	152	199	8	IPR001478
Domain	VWFA	ITGB7 PARP4 INTS14 COL6A3 ITIH5 ANTXRL	2.43e-04	82	199	6	PS50234
Domain	-	MYCBP2 IL18R1 NCR3 AREL1 PTPRD NOMO2 MYPN UNC5D COL6A3 MYOT MYOM3 OBSL1 CCDC141 NOMO1 ANTXRL IGFBP7 OSMR NOMO3	2.71e-04	663	199	18	2.60.40.10
Domain	VWA	ITGB7 PARP4 INTS14 COL6A3 ITIH5 ANTXRL	2.77e-04	84	199	6	SM00327
Domain	CarboxyPept_regulatory_dom	NOMO2 NOMO1 NOMO3	3.15e-04	13	199	3	IPR014766
Domain	-	NOMO2 NOMO1 NOMO3	3.15e-04	13	199	3	2.60.40.1120
Domain	FerA	DYSF FER1L5	3.36e-04	3	199	2	SM01200
Domain	Ferlin_A-domain	DYSF FER1L5	3.36e-04	3	199	2	IPR012560
Domain	FerA	DYSF FER1L5	3.36e-04	3	199	2	PF08165
Domain	MULTICOPPER_OXIDASE2	HEPHL1 CP	3.36e-04	3	199	2	PS00080
Domain	ASD1	SHROOM3 SHROOM2	3.36e-04	3	199	2	PF08688
Domain	ASD1_dom	SHROOM3 SHROOM2	3.36e-04	3	199	2	IPR014800
Domain	ASD1	SHROOM3 SHROOM2	3.36e-04	3	199	2	PS51306
Domain	Dynein_heavy_chain_D4_dom	DNAH5 DYNC1H1 DYNC2H1	3.98e-04	14	199	3	IPR024317
Domain	Dynein_HC_stalk	DNAH5 DYNC1H1 DYNC2H1	3.98e-04	14	199	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH5 DYNC1H1 DYNC2H1	3.98e-04	14	199	3	IPR013602
Domain	DHC_N2	DNAH5 DYNC1H1 DYNC2H1	3.98e-04	14	199	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH5 DYNC1H1 DYNC2H1	3.98e-04	14	199	3	IPR011704
Domain	MT	DNAH5 DYNC1H1 DYNC2H1	3.98e-04	14	199	3	PF12777
Domain	AAA_8	DNAH5 DYNC1H1 DYNC2H1	3.98e-04	14	199	3	PF12780
Domain	AAA_5	DNAH5 DYNC1H1 DYNC2H1	3.98e-04	14	199	3	PF07728
Domain	DHC_fam	DNAH5 DYNC1H1 DYNC2H1	4.93e-04	15	199	3	IPR026983
Domain	Dynein_heavy	DNAH5 DYNC1H1 DYNC2H1	4.93e-04	15	199	3	PF03028
Domain	Dynein_heavy_dom	DNAH5 DYNC1H1 DYNC2H1	4.93e-04	15	199	3	IPR004273
Domain	DH_1	NET1 ARHGEF11 VAV3 ARHGEF2 SOS1	5.56e-04	63	199	5	PS00741
Domain	Ig-like_fold	MYCBP2 IL18R1 NCR3 AREL1 PTPRD NOMO2 MYPN UNC5D COL6A3 MYOT MYOM3 OBSL1 CCDC141 NOMO1 ANTXRL IGFBP7 OSMR NOMO3	5.71e-04	706	199	18	IPR013783
Domain	ATPase_P-typ_TM_dom	TMEM94 ATP1A3 ATP12A	6.02e-04	16	199	3	IPR023298
Domain	-	TMEM94 ATP1A3 ATP12A	6.02e-04	16	199	3	1.20.1110.10
Domain	DnaJ	DNAJA4 DNAJA1	6.68e-04	4	199	2	IPR012724
Domain	DnaJ_CXXCXGXG	DNAJA4 DNAJA1	6.68e-04	4	199	2	PF00684
Domain	-	DNAJA4 DNAJA1	6.68e-04	4	199	2	2.10.230.10
Domain	Cu-oxidase_2	HEPHL1 CP	6.68e-04	4	199	2	IPR011706
Domain	Shroom_fam	SHROOM3 SHROOM2	6.68e-04	4	199	2	IPR027685
Domain	ASD2_dom	SHROOM3 SHROOM2	6.68e-04	4	199	2	IPR014799
Domain	DysFC	DYSF FER1L5	6.68e-04	4	199	2	SM00694
Domain	DysFN	DYSF FER1L5	6.68e-04	4	199	2	SM00693
Domain	ASD2	SHROOM3 SHROOM2	6.68e-04	4	199	2	PF08687
Domain	ZF_CR	DNAJA4 DNAJA1	6.68e-04	4	199	2	PS51188
Domain	ASD2	SHROOM3 SHROOM2	6.68e-04	4	199	2	PS51307
Domain	Peroxin/Ferlin	DYSF FER1L5	6.68e-04	4	199	2	IPR006614
Domain	Cu-oxidase_2	HEPHL1 CP	6.68e-04	4	199	2	PF07731
Domain	VWF_A	ITGB7 PARP4 INTS14 COL6A3 ITIH5 ANTXRL	6.68e-04	99	199	6	IPR002035
Domain	ATPase_P-typ_cation-transptr_C	TMEM94 ATP1A3 ATP12A	7.26e-04	17	199	3	IPR006068
Domain	Cation_ATPase_C	TMEM94 ATP1A3 ATP12A	7.26e-04	17	199	3	PF00689
Domain	CarboxyPept-like_regulatory	NOMO2 NOMO1 NOMO3	7.26e-04	17	199	3	IPR008969
Domain	FerI	DYSF FER1L5	1.11e-03	5	199	2	SM01202
Domain	FerB	DYSF FER1L5	1.11e-03	5	199	2	SM01201
Domain	Ferlin_B-domain	DYSF FER1L5	1.11e-03	5	199	2	IPR012561
Domain	DOCK_N	DOCK5 DOCK1	1.11e-03	5	199	2	PF16172
Domain	AA_TRANSFER_CLASS_5	AGXT MOCOS	1.11e-03	5	199	2	PS00595
Domain	DOCK_N	DOCK5 DOCK1	1.11e-03	5	199	2	IPR032376
Domain	Ferlin_C	DYSF FER1L5	1.11e-03	5	199	2	PF16165
Domain	Ferlin_C	DYSF FER1L5	1.11e-03	5	199	2	IPR032362
Domain	FerIin_dom	DYSF FER1L5	1.11e-03	5	199	2	IPR012968
Domain	FerI	DYSF FER1L5	1.11e-03	5	199	2	PF08151
Domain	FerB	DYSF FER1L5	1.11e-03	5	199	2	PF08150
Domain	Cu-oxidase_3	HEPHL1 CP	1.11e-03	5	199	2	IPR011707
Domain	MULTICOPPER_OXIDASE1	HEPHL1 CP	1.11e-03	5	199	2	PS00079
Domain	Cu_oxidase_CS	HEPHL1 CP	1.11e-03	5	199	2	IPR033138
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	FAM114A1 MYCBP2 SPTB DYSF PARP4 KARS1 DST MYPN PLEC MGA UTRN VCP COL6A3 MYOT DSP MYOM3 ZNF407 CCDC141 PREPL TRIM32	2.67e-11	497	208	20	23414517
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	UAP1 RAPGEF6 NET1 MYCBP2 CCDC18 KDM3B MPDZ GIGYF1 TRIP12 DST PI4KA BOD1L1 PLEC UTRN SHROOM3 SASH1 DSP FAM171A1 NKD2 GAN ARHGEF2 PATJ FGD6 DCLK1 AHNAK2	8.78e-11	861	208	25	36931259
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	ARID4B CMTR1 MYCBP2 CCDC18 CEP76 ARHGAP11A TRIP12 CDAN1 KARS1 DST PI4KA HPX CHD6 UTRN CEP290 MUS81 CP LCP1 MIER1 SNX1	2.48e-09	645	208	20	25281560
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYCBP2 SPTB TRIP12 SARS2 DST PTPRD NOMO2 MTMR3 TAOK1 CHD6 PLEC ZNF606 DNAJA1 UTRN DYNC1H1 VCP DSP CEP290 KCNAB2 OBSL1 ZNF521 SHROOM2 PREPL TRIM32 SENP6 DCLK1 SNX1 SOS1	3.89e-09	1285	208	28	35914814
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	STOX1 ARHGAP11A TRIP12 USP20 DOCK5 PARP4 KARS1 DST PI4KA BOD1L1 CHD6 DNAJA1 UTRN DYNC1H1 HSPD1 LAMB4 REM1 RARS1 DSP CEP290 MYOM3	4.21e-09	736	208	21	29676528
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	MYCBP2 MPDZ TRIP12 PHKA1 DST ERAL1 MKI67 MAP7D2 TASOR RARS1 GNE SNX1	6.71e-09	212	208	12	33853758
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	KDM3B E2F7 TRIP12 MKI67 BOD1L1 PLEC MGA DYNC1H1 HSPD1 DSP NAT10 OTUD4 ACSL5	1.19e-08	272	208	13	31010829
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	GAK MYCBP2 CCDC18 MPDZ CLPX SARS2 NOMO2 DNAJA4 ERAL1 PI4KA MAP7D2 CCDC97 UQCRC2 DNAJA1 VCP HSPD1 CUL2 SHROOM3 CISD2 DYNC2H1 OBSL1 SLC6A15 PREPL NOMO1 FAM171A1 CAMKK2 NAT10 VPS13B SNX1	2.30e-08	1487	208	29	33957083
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	CLPX ARHGEF11 KARS1 NOMO2 USP4 VAV3 PLEC DYNC1H1 HSPD1 KCNAB2 XDH LCP1 NOMO1 NOMO3	2.44e-08	344	208	14	30333137
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DIS3L2 MYCBP2 CLPX TRIP12 KARS1 DST ADSS2 CDC40 ERAL1 PI4KA MKI67 UQCRC2 PLEC MGA DNAJA1 UTRN DYNC1H1 VCP HSPD1 RARS1 GNE DSP GSPT1 TRIM32 NAT10 ARHGEF2 AHNAK2	4.64e-08	1353	208	27	29467282
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ZBTB17 ARID4B SPTA1 ARHGAP11A TRIP12 DOCK5 INTS14 KARS1 DST CDC40 ZSCAN30 MKI67 CHD6 MGA DNAJA1 TASOR CREB3L2 HSPD1 DSP CEP290 MUS81 SP110 MIER1 SNIP1 NAT10 PCCA	7.37e-08	1294	208	26	30804502
Pubmed	Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.	CLPX DST SRL BOD1L1 UQCRC2 PLEC DNAH5 DYNC1H1 HSPD1 DSP SHANK3 PCCA VPS13B	1.18e-07	331	208	13	29199018
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO2 NOMO1 NOMO3	2.11e-07	3	208	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO2 NOMO1 NOMO3	2.11e-07	3	208	3	25576386
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	SPTA1 SPTB DST UQCRC2 DYNC1H1 VCP HSPD1 CUL2 CALB1 SASH1 KCNAB2 SLC1A4 GSPT1 EHHADH ARHGEF2 ATP12A DCLK1	2.41e-07	621	208	17	22794259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYCBP2 MPDZ DAPK1 ARHGEF11 DST PTPRD DNAJA4 PI4KA MGA DNAJA1 DYNC1H1 CACNA1E SHROOM3 KCNAB2 PREPL SHANK3 FAM171A1 NAT10 OTUD4 ARHGEF2 DCLK1	3.91e-07	963	208	21	28671696
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	RAPGEF6 KDM3B MPDZ GIGYF1 CLPX DOCK5 PARP4 DST CDC40 UQCRC2 TASOR MOCOS CUL2 OBSL1 TRIM32 ARHGEF2 PATJ	4.54e-07	650	208	17	38777146
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GAK SPTA1 SPTB DAPK1 ARHGEF11 KARS1 DST PI4KA MAP7D2 USP4 UQCRC2 PLEC UTRN DYNC1H1 VCP HSPD1 DSP KCNAB2 SHROOM2 AQP4 SLC1A4 SHANK3 OTUD4 ARHGEF2 ATP1A3 DCLK1	5.08e-07	1431	208	26	37142655
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TRIP12 DOCK5 PARP4 ERAL1 TAOK1 PLEC DNAJA1 DYNC1H1 KNL1 HSPD1 DOCK1 SHROOM3 DSP GSPT1 NAT10 ARHGEF2	5.21e-07	582	208	16	20467437
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	FAM114A1 NLRP7 SPTA1 MB STOX1 CLPX TRIP12 DST DNAJA4 MAP7D2 BOD1L1 CHD6 UQCRC2 PLEC DNAJA1 TASOR HSPD1 CACNA1E DSP PCDHGA3 LCP1 GSPT1 YBX2 ARHGEF2 ATP1A3 ATP12A	5.86e-07	1442	208	26	35575683
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	RAPGEF6 NET1 TRIP12 AREL1 INTS14 ERAL1 PI4KA MYPN TAOK1 BOD1L1 PLEC MGA TASOR UTRN XPA SHROOM2 MIER1 NAT10 OTUD4 PATJ DCLK1 VPS13B	6.78e-07	1084	208	22	11544199
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	DOCK5 KARS1 DNAJA4 ERAL1 PI4KA MKI67 CHD6 HSF1 MGA TASOR DYNC1H1 HSPD1 SHROOM3 CISD2 DSP DYNC2H1 NAT10 SNX1	7.69e-07	754	208	18	35906200
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO2 NOMO1 NOMO3	8.40e-07	4	208	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO2 NOMO1 NOMO3	8.40e-07	4	208	3	9267806
Pubmed	Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin beta4 cytoplasmic domain.	IVL DST MKI67 PLEC	8.52e-07	13	208	4	9670011
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	CDHR5 GFUS DYSF PARP4 HPX TAOK1 DNAJA1 UTRN DYNC1H1 VCP HSPD1 COL6A3 CALB1 RARS1 DSP DYNC2H1 CP LCP1 SHROOM2 CAPN7 PATJ	9.23e-07	1016	208	21	19056867
Pubmed	POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.	ARID4B CHD6 PLEC DNAH5 KNL1 HSPD1 SHROOM3 RARS1 DSP PATJ SOS1	1.01e-06	277	208	11	30745168
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RAPGEF6 ARID4B MYCBP2 KDM3B TRIP12 MKI67 TAOK1 PLEC HSF1 UNC5D MOCOS SEC16B DSP MIER1 OTUD4 SENP6 ARHGEF2 SOS1	1.12e-06	774	208	18	15302935
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	KARS1 DST CDC40 UQCRC2 PLEC DYNC1H1 VCP HSPD1 SHROOM3 RARS1 DSP GSPT1 TRIM32 GAN	1.28e-06	477	208	14	31300519
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	NET1 MYCBP2 CEP76 GIGYF1 IVL DOCK5 KARS1 KATNIP UQCRC2 PLEC HSF1 DYNC1H1 CUL2 DYNC2H1 CEP290 OBSL1 NOMO1 EAF1 TRIM32 GAN PRKG2 FGD6 DCLK1 CCDC144A	1.45e-06	1321	208	24	27173435
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYCBP2 CCDC18 CLPX PHKA1 KARS1 PTPRD PI4KA MKI67 MTMR3 UQCRC2 FTO DNAJA1 UTRN KNL1 DSP CEP290 SLC6A15 FAM171A1 NAT10 OTUD4 ARHGEF2	1.53e-06	1049	208	21	27880917
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	CMTR1 KDM3B MKI67 MGA DYNC1H1 HSPD1 RARS1 DSP MUS81 NKD2 PCCA SNX1	1.87e-06	357	208	12	37059091
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TBC1D9B CMTR1 USP20 PARP4 TAOK1 ZNF606 MGA TASOR SEC16B DYNC2H1 CEP290 ZNF407 SHANK3 FGD6	1.88e-06	493	208	14	15368895
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	UAP1 MYCBP2 SPTA1 DAPK1 DST ADSS2 PLEC UTRN DYNC1H1 VCP HSPD1 RARS1 CISD2 DSP DYNC2H1 CP PCCA AHNAK2	2.01e-06	807	208	18	30575818
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	RAPGEF6 TRIP12 IVL DOCK5 CDC40 PLEC MGA DYNC1H1 DOCK1 SHROOM3 CCDC141 PATJ SOS1	2.23e-06	430	208	13	35044719
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	GAK MYCBP2 TMEM94 KDM3B MPDZ NOMO2 BOD1L1 CHD6 MGA DNAJA1 TASOR KNL1 CEP290 SHC4 SLC6A15 ARHGEF2 PATJ	2.32e-06	733	208	17	34672954
Pubmed	Misregulation of an Activity-Dependent Splicing Network as a Common Mechanism Underlying Autism Spectrum Disorders.	RAPGEF6 SRRM4 PTPRD DYNC2H1	3.56e-06	18	208	4	27984743
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MYCBP2 TRIP12 DST ERAL1 PI4KA MKI67 UQCRC2 PLEC MGA DNAJA1 UTRN DYNC1H1 VCP HSPD1 RARS1 DSP CEP290 OBSL1 NAT10 ARHGEF2	3.97e-06	1024	208	20	24711643
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SRRM4 KDM3B ARHGAP11A KARS1 DST FTO SHROOM3 SASH1 MIER1 PREPL CAMKK2 NAT10 SENP6 KDM7A	4.23e-06	529	208	14	14621295
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GAK RAPGEF6 MYCBP2 KDM3B MPDZ BOD1L1 MGA DYNC1H1 RARS1 DSP NAT10 PATJ PCCA SNX1	6.44e-06	549	208	14	38280479
Pubmed	Limb-Girdle Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	DYSF PLEC MYOT TRIM32	6.87e-06	21	208	4	20301582
Pubmed	A human MAP kinase interactome.	ARID4B ARHGEF11 DST VAV3 CHD6 CCDC97 PLEC MGA HSPD1 DOCK1 DSP CEP290 SOS1	8.36e-06	486	208	13	20936779
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	SRRM4 SPTB ARHGAP11A ITGB7 PARP4 PTPRD ADSS2 SRL HEPHL1 XDH XPA SP110 SERPINA12 OSMR ATP12A PATJ DCLK1	9.21e-06	814	208	17	23251661
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RAPGEF6 MYCBP2 DST CHD6 PLEC MGA TASOR UTRN KNL1 DSP ZFHX4 PCCA	9.28e-06	418	208	12	34709266
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	NET1 MYCBP2 KDM3B MPDZ CLPX TRIP12 USP20 ERCC8 SARS2 USP4 PLEC UTRN VCP CUL2 LAMB4 DYNC2H1 PREPL OTUD4 ARHGEF2	1.11e-05	1005	208	19	19615732
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	NET1 MPDZ CLPX ARHGAP11A ARHGEF11 DOCK5 VAV3 PLEC MGA UTRN DOCK1 PREPL GSPT1 TRIM32 ARHGEF2 PATJ FGD6 SOS1	1.14e-05	916	208	18	32203420
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO2 NOMO1 NOMO3	1.15e-05	8	208	3	15257293
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	NET1 DYSF DST TAOK1 CHD6 PLEC MGA DNAJA1 UTRN COL6A3 MIER1	1.33e-05	363	208	11	14691545
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ARID4B NET1 GAS6 GIGYF1 CLPX INTS14 MGA DNAJA1 UNC5D VCP KNL1 OBSL1 SP110 SNIP1 EAF1 ZFHX4 NAT10 OSMR PCCA SOS1	1.39e-05	1116	208	20	31753913
Pubmed	Functional proteomics mapping of a human signaling pathway.	MYCBP2 KDM3B TRIP12 DST CHD6 PLEC MGA UTRN DYNC1H1 KNL1 SASH1 NOMO1 SNIP1 NOMO3	1.47e-05	591	208	14	15231748
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GAK RAPGEF6 KDM3B KARS1 DST MKI67 BOD1L1 TASOR UTRN VCP KNL1 HSPD1 DSP NAT10 SENP6 PCCA SNX1 AHNAK2	1.47e-05	934	208	18	33916271
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ARHGEF11 NOMO2 MAP7D2 PLEC MGA DNAJA1 DYNC1H1 HSPD1 SHROOM3 DSP CEP290 CP LCP1 MEIOC CAPN7 ARHGEF2 PCCA	1.68e-05	853	208	17	28718761
Pubmed	Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome.	MKI67 CALB1 CEP290	1.72e-05	9	208	3	21623382
Pubmed	Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly.	DST PLEC DSP	1.72e-05	9	208	3	12482924
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO2 NOMO1 NOMO3	1.72e-05	9	208	3	36261522
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	SPTA1 SPTB DST PLEC HSPD1 COL6A3 DYNC2H1 GAN	1.83e-05	187	208	8	26460568
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	RAPGEF6 NET1 E2F7 GIGYF1 PI4KA MGA XPA P3H2 OTUD4 SNX1 AHNAK2	1.94e-05	378	208	11	34315543
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	DST PLEC UTRN DYNC1H1 VCP HSPD1 NOMO1 NOMO3	2.13e-05	191	208	8	33762435
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	SPTA1 SPTB MKI67	2.45e-05	10	208	3	22159418
Pubmed	The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.	GIGYF1 KARS1 UQCRC2 DNAJA1 VCP HSPD1 RARS1 DSP NOMO1 OTUD4	2.55e-05	320	208	10	28685749
Pubmed	Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants.	CLPX KARS1 UQCRC2 DNAJA1 DYNC1H1 HSPD1 RARS1 TRIM32 ATP1A3	2.60e-05	256	208	9	35777956
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	RAPGEF6 MYPN PLEC DYNC1H1 KNL1 RARS1 DSP SNX1 AHNAK2	2.60e-05	256	208	9	33397691
Pubmed	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.	TRIP12 UQCRC2 DNAJA1 DYNC1H1 VCP HSPD1 ATP1A3	2.72e-05	144	208	7	35681168
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CLPX TRIP12 KARS1 SARS2 CDC40 ERAL1 MKI67 PIMREG TAOK1 UQCRC2 PLEC DYNC1H1 VCP SEC16B RARS1 DSP OBSL1 SNIP1 EHHADH NAT10 OTUD4 ARHGEF2	2.78e-05	1371	208	22	36244648
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	E2F7 CLPX KARS1 PLEC MGA TASOR VCP HSPD1 RARS1 DSP NAT10 OTUD4 ARHGEF2	3.11e-05	551	208	13	34728620
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	TRIP12 DOCK5 PARP4 PI4KA PLEC DOCK1 DSP ARHGEF2	3.17e-05	202	208	8	33005030
Pubmed	Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediate filaments is mediated by distinct sequences within their COOH terminus.	DST PLEC DSP	3.36e-05	11	208	3	12802069
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO2 NOMO1 NOMO3	3.36e-05	11	208	3	32820719
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	MYCBP2 ARHGAP11A SHROOM3 SASH1 TRIM32 GAN	3.56e-05	102	208	6	15778465
Pubmed	The protective roles of integrin α4β7 and Amphiregulin-expressing innate lymphoid cells in lupus nephritis.	ITGA4 ITGB7	3.56e-05	2	208	2	38806623
Pubmed	A deletional frameshift mutation of the beta-spectrin gene associated with elliptocytosis in spectrin Tokyo (beta 220/216).	SPTA1 SPTB	3.56e-05	2	208	2	1391962
Pubmed	Binding of HIV-1 virions to α4β 7 expressing cells and impact of antagonizing α4β 7 on HIV-1 infection of primary CD4+ T cells.	ITGA4 ITGB7	3.56e-05	2	208	2	25527342
Pubmed	Cryptic determinant of α4β7 binding in the V2 loop of HIV-1 gp120.	ITGA4 ITGB7	3.56e-05	2	208	2	25265384
Pubmed	Chaperone activity and prodan binding at the self-associating domain of erythroid spectrin.	SPTA1 SPTB	3.56e-05	2	208	2	15492010
Pubmed	Beta spectrin kissimmee: a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1.	SPTA1 SPTB	3.56e-05	2	208	2	8102379
Pubmed	Beta-spectrin Promiss-ao: a translation initiation codon mutation of the beta-spectrin gene (ATG --> GTG) associated with hereditary spherocytosis and spectrin deficiency in a Brazilian family.	SPTA1 SPTB	3.56e-05	2	208	2	9414314
Pubmed	Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.	ITGA4 ITGB7	3.56e-05	2	208	2	26625359
Pubmed	The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission.	ITGA4 ITGB7	3.56e-05	2	208	2	21383973
Pubmed	Mutation of a highly conserved residue of betaI spectrin associated with fatal and near-fatal neonatal hemolytic anemia.	SPTA1 SPTB	3.56e-05	2	208	2	9005995
Pubmed	Identification of the molecular defect in the erythrocyte membrane skeleton of some kindreds with hereditary spherocytosis.	SPTA1 SPTB	3.56e-05	2	208	2	7104494
Pubmed	A genetic defect in the binding of protein 4.1 to spectrin in a kindred with hereditary spherocytosis.	SPTA1 SPTB	3.56e-05	2	208	2	6215583
Pubmed	Conservancy of the α4β7 integrin mimotope in the V2 domain of HIV type 1 CRF07_BC compared to subtype B' strains in China.	ITGA4 ITGB7	3.56e-05	2	208	2	21417760
Pubmed	Neurovascular dysfunction and neuroinflammation in a Cockayne syndrome mouse model.	ERCC8 XPA	3.56e-05	2	208	2	34628368
Pubmed	Virion attachment and entry: HIV gp120 Env biotinylation, gp120 Env, or integrin ligand-binding assay.	ITGA4 ITGB7	3.56e-05	2	208	2	24158809
Pubmed	Preferential loss of gut-homing α4β7 CD4+ T cells and their circulating functional subsets in acute HIV-1 infection.	ITGA4 ITGB7	3.56e-05	2	208	2	26277899
Pubmed	Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells.	HEPHL1 CP	3.56e-05	2	208	2	20685892
Pubmed	Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes.	ITGA4 ITGB7	3.56e-05	2	208	2	29367348
Pubmed	South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication.	ITGA4 ITGB7	3.56e-05	2	208	2	26105197
Pubmed	Genetic analysis of the cytoplasmic dynein subunit families.	DYNC1H1 DYNC2H1	3.56e-05	2	208	2	16440056
Pubmed	Conservation of the α4β7 lymphocyte homing receptor in HIV-infected patients with distinct transmission routes and disease progression profiles.	ITGA4 ITGB7	3.56e-05	2	208	2	24387749
Pubmed	Spectrin Nice (beta 220/216): a shortened beta-chain variant associated with an increase of the alpha I/74 fragment in a case of elliptocytosis.	SPTA1 SPTB	3.56e-05	2	208	2	3580577
Pubmed	Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene.	SPTA1 SPTB	3.56e-05	2	208	2	7883966
Pubmed	The Placental Ferroxidase Zyklopen Is Not Essential for Iron Transport to the Fetus in Mice.	HEPHL1 CP	3.56e-05	2	208	2	34114013
Pubmed	Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin.	ITGA4 ITGB7	3.56e-05	2	208	2	11981833
Pubmed	Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms.	MKI67 VCP	3.56e-05	2	208	2	15452376
Pubmed	Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection.	ITGA4 ITGB7	3.56e-05	2	208	2	19795986
Pubmed	Apparent but unconfirmed digenism in an Iranian consanguineous family with syndromic Retinal Disease.	MKKS CEP290	3.56e-05	2	208	2	33741323
Pubmed	Spectrin Cosenza: a novel beta chain variant associated with Sp alphaI/74 hereditary elliptocytosis.	SPTA1 SPTB	3.56e-05	2	208	2	9163587
Pubmed	Identification of three novel spectrin alpha I/74 mutations in hereditary elliptocytosis: further support for a triple-stranded folding unit model of the spectrin heterodimer contact site.	SPTA1 SPTB	3.56e-05	2	208	2	8018926
Pubmed	Combining Cep290 and Mkks ciliopathy alleles in mice rescues sensory defects and restores ciliogenesis.	MKKS CEP290	3.56e-05	2	208	2	22446187
Interaction	YWHAH interactions	UAP1 RAPGEF6 NET1 MYCBP2 CCDC18 KDM3B MPDZ GIGYF1 TRIP12 DST PI4KA MTMR3 USP4 TAOK1 BOD1L1 PLEC UTRN VCP SHROOM3 REM1 SASH1 DSP CEP290 FAM171A1 NKD2 TRIM32 ARHGEF2 PATJ FGD6 DCLK1 AHNAK2	2.33e-07	1102	204	31	int:YWHAH
Interaction	YWHAQ interactions	UAP1 RAPGEF6 ZBTB17 NLRP7 MYCBP2 SPTA1 SPTB CCDC18 DAPK1 GIGYF1 TRIP12 DST ADSS2 TAOK1 PLEC HSF1 DYNC1H1 VCP CUL2 SHROOM3 REM1 SASH1 OBSL1 SHANK3 FAM171A1 SLC8A3 NKD2 TRIM32 ARHGEF2 FGD6 DCLK1	3.19e-07	1118	204	31	int:YWHAQ
Interaction	YWHAG interactions	UAP1 RAPGEF6 NET1 MYCBP2 CCDC18 KDM3B MPDZ GIGYF1 ITGA4 TRIP12 DST PI4KA MTMR3 TAOK1 BOD1L1 UTRN DYNC1H1 VCP HSPD1 SHROOM3 SASH1 DSP SHROOM2 SHANK3 FAM171A1 SNIP1 NKD2 TRIM32 ARHGEF2 PATJ FGD6 DCLK1 AHNAK2	3.72e-07	1248	204	33	int:YWHAG
Interaction	SPTAN1 interactions	GAK MYCBP2 SPTB DAPK1 CEP76 USP20 CCDC112 KARS1 SARS2 DST PLEC DNAJA1 VCP SHANK3 GSPT1 HASPIN GAN SOS1	3.21e-06	496	204	18	int:SPTAN1
Interaction	SFN interactions	UAP1 RAPGEF6 MYCBP2 CCDC18 GIGYF1 ARHGAP11A TRIP12 IVL DST USP4 PLEC VCP SHROOM3 SASH1 FAM171A1 CAMKK2 TRIM32 GAN ARHGEF2 FGD6 AHNAK2	7.80e-06	692	204	21	int:SFN
Interaction	YWHAZ interactions	UAP1 RAPGEF6 MYCBP2 SPTA1 CCDC18 GIGYF1 ITGA4 TRIP12 DST MTMR3 KATNIP UQCRC2 PLEC HSF1 DYNC1H1 VCP CUL2 SHROOM3 REM1 SASH1 KCNAB2 OBSL1 SHANK3 FAM171A1 NKD2 TRIM32 OTUD4 GAN ARHGEF2 FGD6 DCLK1	9.87e-06	1319	204	31	int:YWHAZ
Interaction	YWHAE interactions	UAP1 RAPGEF6 MYCBP2 CCDC18 GIGYF1 ITGA4 TRIP12 DST AGXT MTMR3 PIMREG HSF1 MGA DNAJA1 DYNC1H1 VCP SHROOM3 REM1 SASH1 OBSL1 SHROOM2 SHANK3 FAM171A1 SLC8A3 NKD2 TRIM32 CAPN7 ARHGEF2 FGD6 DCLK1	1.03e-05	1256	204	30	int:YWHAE
Interaction	RCOR1 interactions	RAPGEF6 MYCBP2 DST MKI67 CHD6 PLEC MGA DNAJA1 TASOR UTRN VCP KNL1 DSP MIER1 GSPT1 ZFHX4 PCCA	1.22e-05	494	204	17	int:RCOR1
Interaction	BAG2 interactions	GAK RAPGEF6 KDM3B DAPK1 DOCK5 ERCC8 INTS14 DNAJA4 BOD1L1 HSF1 DNAJA1 VCP KNL1 OBSL1 SP110 TRIM32 OTUD4 VPS13B SNX1	1.97e-05	622	204	19	int:BAG2
Interaction	YWHAB interactions	UAP1 RAPGEF6 MYCBP2 CCDC18 DAPK1 GIGYF1 ITGA4 TRIP12 DST MTMR3 USP4 TAOK1 DYNC1H1 VCP SHROOM3 SASH1 SHANK3 FAM171A1 SLC8A3 NKD2 TRIM32 ARHGEF2 FGD6 DCLK1 AHNAK2	3.60e-05	1014	204	25	int:YWHAB
Interaction	DYNLT1 interactions	RAPGEF6 ARID4B DST PLEC DNAJA1 TASOR DYNC1H1 KNL1 CP ARHGEF2 PCCA	3.65e-05	241	204	11	int:DYNLT1
Interaction	NUDC interactions	ITGA4 ERCC8 KARS1 USP4 BOD1L1 HSF1 DNAJA1 DYNC1H1 VCP CUL2 RARS1 SHANK3 OTUD4	4.17e-05	337	204	13	int:NUDC
Interaction	KCNA4 interactions	CCDC112 UTRN PCDHGA3 KCNAB2 OBSL1 PATJ	6.49e-05	68	204	6	int:KCNA4
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	NET1 ARHGEF11 VAV3 ARHGEF2 FGD6 SOS1	8.95e-06	66	133	6	722
GeneFamily	PDZ domain containing	RAPGEF6 MPDZ ARHGEF11 SHROOM3 SHROOM2 SHANK3 PATJ AHNAK2	1.67e-05	152	133	8	1220
GeneFamily	EF-hand domain containing\|Plakins	DST PLEC DSP	2.12e-05	8	133	3	939
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PTPRD MYPN UNC5D MYOT MYOM3 OBSL1 IGFBP7	1.90e-04	161	133	7	593
GeneFamily	EF-hand domain containing	TBC1D9B SPTA1 EFCAB13 DST CACNA1E CALB1 LCP1 NKD2	2.19e-04	219	133	8	863
GeneFamily	Bardet-Biedl syndrome associated\|BBSome	MKKS CEP290 TRIM32	4.70e-04	21	133	3	980
GeneFamily	Ferlin family	DYSF FER1L5	7.90e-04	6	133	2	828
GeneFamily	EF-hand domain containing\|Spectrins	SPTA1 SPTB	1.10e-03	7	133	2	1113
GeneFamily	PDZ domain containing\|Crumbs complex	MPDZ PATJ	1.87e-03	9	133	2	1223
GeneFamily	Dyneins, cytoplasmic	DYNC1H1 DYNC2H1	3.97e-03	13	133	2	538
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	NET1 SPTB VAV3 ARHGEF2 FGD6 SOS1	4.21e-03	206	133	6	682
GeneFamily	Chaperonins	MKKS HSPD1	5.30e-03	15	133	2	587
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	GAK DNAJA4 DNAJA1	5.60e-03	49	133	3	584
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CDKN2D RAPGEF6 MYCBP2 SRRM4 GIGYF1 CCDC112 MAP7D2 BOD1L1 VAV3 CACNA1E SHC4 SLC6A15 XPA SHROOM2 CCDC141 PREPL SHANK3 ZNF28 ZFHX4 OTUD4 ATP1A3 DCLK1 SNX1 CCDC144A AHNAK2	2.20e-06	1106	206	25	M39071
Coexpression	GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN	ARID4B MYCBP2 USP20 DOCK5 DNAJA4 DSP ZNF521 SLC6A15 OTUD4 MSLN	4.44e-06	200	206	10	M4373
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME2	B3GALT4 NET1 SRRM4 GAS6 PTGR2 DYSF DNAJA4 MAP7D2 YBX2 SLC8A3 NKD2 PRKG2 ATP1A3 PATJ RAPGEFL1	9.18e-06	493	206	15	M1951
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME2	B3GALT4 NET1 SRRM4 GAS6 PTGR2 DYSF DNAJA4 MAP7D2 YBX2 SLC8A3 NKD2 PRKG2 ATP1A3 PATJ RAPGEFL1	1.19e-05	504	206	15	MM830
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MYCBP2 KDM3B DAPK1 ARHGAP11A TRIP12 DST MTMR3 FTO TASOR CREB3L2 DOCK1 CUL2 SASH1 GNE FAM171A1 OTUD4 OSMR PCCA VPS13B SOS1	1.52e-05	856	206	20	M4500
Coexpression	HALLMARK_MITOTIC_SPINDLE	RAPGEF6 NET1 ARHGEF11 DST DYNC1H1 SHROOM2 ARHGEF2 FGD6 SOS1	2.98e-05	199	206	9	M5893
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP	UAP1 TBC1D9B RAPGEF6 KDM3B SRL BOD1L1 SASH1 SHC4 TRIM32	3.10e-05	200	206	9	M6653
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	GAK ARID4B CMTR1 CEP76 SARS2 MKI67 MAP7D2 BOD1L1 VAV3 TASOR DYNC1H1 DYNC2H1 ZNF407 LCP1 DCLRE1C SENP6 GAN ATP1A3 PCCA SOS1	1.04e-06	595	201	20	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	FAM114A1 GAS6 MPDZ CPQ SLC10A6 CREB3L2 DOCK1 COL6A3 SASH1 XDH CP ITIH5 IGFBP7 OSMR DCLK1	2.37e-05	445	201	15	GSM777043_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	GAK RAPGEF6 ARID4B CMTR1 MYCBP2 MKI67 VAV3 TASOR UTRN KNL1 GNE CISD2 ZNF407 DCLRE1C PCCA FGD6 SOS1	2.81e-05	564	201	17	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS6 PTPRD DNAH5 DOCK1 COL6A3 REM1 CP NKD2 ZFHX4 IGFBP7 OSMR DCLK1	1.57e-10	196	208	12	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS6 PTPRD DNAH5 DOCK1 COL6A3 REM1 CP NKD2 ZFHX4 IGFBP7 OSMR DCLK1	1.57e-10	196	208	12	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DAPK1 MAP7D2 DNAH5 UTRN SHROOM3 DSP CP AQP4 PATJ DCLK1	3.26e-08	197	208	10	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	NET1 DAPK1 UTRN DSP OBSL1 CP CCDC141 P3H2 PATJ ACSL5	3.26e-08	197	208	10	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	PBMC-Severe\|PBMC / Compartment, Disease Groups and Clusters	CDKN2D GAS6 ITGA4 ITGB7 MKI67 VAV3 LCP1 SP110 IGFBP7 MSLN	3.59e-08	199	208	10	b428d95d3c90b28f658f652a768588a8ced4abd9
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MPDZ DOCK5 DST VAV3 UTRN SASH1 ZNF521 SHANK3 IGFBP7	1.66e-07	178	208	9	ad3de3e03a401dac64431a541899445262246347
ToppCell	Mesenchymal_cells-Adipo-CAR\|World / Lineage and Cell class	GAS6 MPDZ DAPK1 PTPRD SHROOM3 CP SERPINA12 IGFBP7 P3H2	2.42e-07	186	208	9	6ca8ce7ced91d6308b7c056032ffec1b37c974bf
ToppCell	droplet-Limb_Muscle\|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UAP1 CPQ SLC10A6 DNAJA1 COL6A3 ITIH5 ZFHX4 IGFBP7 OSMR	2.89e-07	190	208	9	06c2b13fa88abbcb8086f13b8d98a156e41e4198
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EFCAB13 DAPK1 PARP4 DNAH5 UNC5D DOCK1 SASH1 GNE P3H2	3.02e-07	191	208	9	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GAS6 PTPRD CPQ SLC10A6 COL6A3 SHROOM3 CP IGFBP7 PRKG2	3.02e-07	191	208	9	36467322096bc766cd777dae3bfb4e65511e492c
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GAS6 PTPRD CPQ SLC10A6 COL6A3 SHROOM3 CP IGFBP7 PRKG2	3.02e-07	191	208	9	94795daf05061baa3b72a1b01c9e940af86de044
ToppCell	droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN2D CCDC18 E2F7 ARHGAP11A MKI67 PIMREG KNL1 YBX2 HASPIN	3.16e-07	192	208	9	96f23d6e8604d1cb24910d3118d8171b57c93e14
ToppCell	droplet-Lung-nan-18m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS6 PTPRD CPQ SLC10A6 COL6A3 SHROOM3 CP IGFBP7 PRKG2	3.16e-07	192	208	9	df56c3e3bb1aafc1126607f4426554c09c8c40cf
ToppCell	droplet-Lung-nan-21m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD CPQ SLC10A6 COL6A3 SHROOM3 CP SLC1A4 IGFBP7 PRKG2	3.30e-07	193	208	9	ac4270b26f5dc7ff2220a109e5aae5a113893211
ToppCell	droplet-Lung-nan-21m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD CPQ SLC10A6 COL6A3 SHROOM3 CP SLC1A4 IGFBP7 PRKG2	3.30e-07	193	208	9	7a09739d0b07dcd615cce2da93fd169cc92e566d
ToppCell	COPD-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	DAPK1 GFUS DOCK5 DST VAV3 DSP ZNF521 IGFBP7 P3H2	3.60e-07	195	208	9	e91ce548ae7224661ee5d2f2639794a5f69798ee
ToppCell	Control-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	GFUS DOCK5 DST VAV3 DSP ZNF521 CCDC141 IGFBP7 P3H2	3.76e-07	196	208	9	e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTB PHKA1 MYPN SRL ADSS1 MYOT MYOM3 SLC8A3	4.01e-07	144	208	8	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	LPS_only-Epithelial_airway\|LPS_only / Treatment groups by lineage, cell group, cell type	HEPHL1 DNAH5 CNDP1 DSP CP SLC1A4 GAN ATP12A MSLN	4.09e-07	198	208	9	ba090210392e001a3f7bdf09371b3f0e0c8c7ef3
ToppCell	LPS_only-Epithelial_airway-airway_epithelial\|LPS_only / Treatment groups by lineage, cell group, cell type	HEPHL1 DNAH5 CNDP1 DSP CP SLC1A4 GAN ATP12A MSLN	4.09e-07	198	208	9	e035380578c01b0243bfef29ca9b50cc17cce771
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Airway-Club\|LPS_only / Treatment groups by lineage, cell group, cell type	HEPHL1 DNAH5 CNDP1 DSP CP SLC1A4 GAN ATP12A MSLN	4.27e-07	199	208	9	165ac94b2d56072ad43358b5127d77555221e2d8
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA4 ITGB7 DOCK5 SLC10A6 MKI67 MOCOS DYNC2H1 XDH	6.35e-07	153	208	8	0ef7c45cdd854c79e527006034029767f8e108b2
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	NET1 DAPK1 STOX1 DST PTPRD PLEC FAM171A1 GAN	9.34e-07	161	208	8	347edb0de10850b7d16c40945751033289289c9b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDKN2D CCDC18 E2F7 ARHGAP11A MKI67 PIMREG KNL1 GUCY2F	1.12e-06	165	208	8	eec2d327c94832d1390314c93ef6a2be4648478b
ToppCell	facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA4 IL18R1 ITGB7 DOCK5 MOCOS MYOM3 KCNAB2 XDH	1.12e-06	165	208	8	ab6ed7e30096c418e7be2d5eec33feeddd1387d9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC18 ARHGAP11A MKI67 PIMREG KNL1 LCP1 CCDC141 HASPIN	1.35e-06	169	208	8	54b13ab02b4c187f4754045ecfcf409749e7ccc0
ToppCell	droplet-Lung-1m-Hematologic-myeloid-classical_monocyte\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CDKN2D ITGB7 FES ADSS1 XDH CAMKK2 KDM7A ATP1A3	1.82e-06	176	208	8	3b5d12d5c22e32fbe80c3716ff14a7ae5769c165
ToppCell	droplet-Lung-1m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CDKN2D ITGB7 FES ADSS1 XDH CAMKK2 KDM7A ATP1A3	1.82e-06	176	208	8	8f9d2a763b79cafe26dcbf3dba980d473a0b9873
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	CMTR1 ITGA4 ARHGAP11A DST NOMO2 ZNF407 EAF1 BCO2	1.82e-06	176	208	8	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	B3GALT4 KDM3B CLPX ARHGEF11 ZNF521 YBX2 IGFBP7 MSLN	2.25e-06	181	208	8	f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	ARID4B TRIP12 DST TAOK1 UTRN DSP SP110 FGD6	2.44e-06	183	208	8	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK1 UTRN MOCOS SHROOM3 CP AQP4 PATJ DCLK1	2.54e-06	184	208	8	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	Control-Epithelial_alveolar-AT_2-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK1 SHROOM3 DSP OBSL1 CP P3H2 PATJ ACSL5	2.64e-06	185	208	8	8ca1374501eca01d8468130b74d50abfd4329fbe
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DAPK1 UTRN MOCOS SHROOM3 CP AQP4 PATJ DCLK1	2.75e-06	186	208	8	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MPDZ SLC2A10 DST OBSL1 ZNF521 SHANK3 SLC8A3 PRKG2	3.10e-06	189	208	8	2157a2d40613f7d5ce2e7dbd266df441e449cdaf
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GAS6 PTPRD CPQ SLC10A6 COL6A3 CP IGFBP7 PRKG2	3.10e-06	189	208	8	e76dc36a01d8ad7590b3acc4c46abfcb76857448
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DYSF DOCK5 VAV3 SASH1 DSP ZNF521 SHANK3 IGFBP7	3.22e-06	190	208	8	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	droplet-Lung-18m-Mesenchymal\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GAS6 PTPRD CPQ SLC10A6 COL6A3 CP IGFBP7 PRKG2	3.22e-06	190	208	8	0b7200897b2c389632c9b1ee37e272b811555dbc
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NET1 MYCBP2 GAS6 ITGA4 DST UTRN COL6A3 ITIH5	3.22e-06	190	208	8	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS6 PTPRD CPQ COL6A3 SHROOM3 CP IGFBP7 PRKG2	3.35e-06	191	208	8	a261f0738d974784bbdd60f23092bfbcca464459
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRD CPQ SLC10A6 COL6A3 SHROOM3 REM1 CP PRKG2	3.35e-06	191	208	8	8a73d2df079566fca4cbb5cdb85721c2e87134c8
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS6 PTPRD CPQ COL6A3 SHROOM3 CP IGFBP7 PRKG2	3.35e-06	191	208	8	6594398cc8151c73696391a43ac110c10283dab1
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRD CPQ SLC10A6 COL6A3 SHROOM3 REM1 CP PRKG2	3.35e-06	191	208	8	c715bbdbbf1482aad45a50a16d5232fd35a9a0bb
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRD CPQ SLC10A6 COL6A3 SHROOM3 REM1 CP PRKG2	3.35e-06	191	208	8	243d83cbfcc4996ad087ec6386e559e0b8662004
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRD CPQ SLC10A6 COL6A3 REM1 CP SLC1A4 PRKG2	3.35e-06	191	208	8	b5210de890d338602857b5907135705a507bc2b0
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DAPK1 PTPRD DNAH5 SHROOM3 SHC4 XDH CP PATJ	3.35e-06	191	208	8	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DAPK1 SHROOM3 CCDC141 AQP4 P3H2 PRKG2 ARHGEF2 PATJ	3.35e-06	191	208	8	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DAPK1 SHROOM3 CCDC141 AQP4 P3H2 PRKG2 ARHGEF2 PATJ	3.48e-06	192	208	8	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS6 PTPRD SLC10A6 COL6A3 SHROOM3 CP IGFBP7 PRKG2	3.48e-06	192	208	8	d22c1135867bcb9076435e2c6eb1cc1248990d0c
ToppCell	droplet-Lung-nan-18m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAS6 PTPRD SLC10A6 COL6A3 SHROOM3 CP IGFBP7 PRKG2	3.48e-06	192	208	8	c09966f4d63a739a56db4df7e0e0ee9ecacd21ad
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GAS6 PTPRD CPQ SLC10A6 COL6A3 CP BPIFA2 DCLK1	3.48e-06	192	208	8	1b228f0929b505de82a39bf64c837887b0e56701
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DYSF PTPRD CPQ VAV3 SASH1 ZNF521 SHANK3 FAM171A1	3.62e-06	193	208	8	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	PND28-Mesenchymal-Mesenchymal_structural\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GAS6 PTPRD CPQ COL6A3 CP IGFBP7 PRKG2 MSLN	3.62e-06	193	208	8	ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD CPQ SLC10A6 COL6A3 REM1 CP SLC1A4 PRKG2	3.62e-06	193	208	8	fa45042d30f9cfeed10e23270a78f18551219cfa
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GAS6 PTPRD CPQ COL6A3 CP IGFBP7 PRKG2 MSLN	3.62e-06	193	208	8	30481fb01c7acf85beae10213f038da86bed6777
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD CPQ SLC10A6 COL6A3 REM1 CP SLC1A4 PRKG2	3.62e-06	193	208	8	ab511ea9e09216a965b3ae5a94f8c3c1ae33d944
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK5 DST PTPRD COL6A3 ZNF521 SLC8A3 ZFHX4 PCCA	3.76e-06	194	208	8	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	DOCK5 DST PTPRD COL6A3 ZNF521 SLC8A3 ZFHX4 PCCA	3.90e-06	195	208	8	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDHR5 DNAJA4 SHROOM3 DSP CPA2 SERPINA12 PRKG2 MSLN	3.90e-06	195	208	8	e87b11e3242fdbed2e7f383e6876ec375af32bd4
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	SPTA1 SPTB CCDC18 E2F7 ITGA4 ARHGAP11A MKI67 KNL1	3.90e-06	195	208	8	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 PTPRD CPQ CREB3L2 MYOT CP ITIH5 ZFHX4	3.90e-06	195	208	8	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	COVID-19-Heart-Mito_CM\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTB MB MYPN SRL ADSS1 MYOT DSP MYOM3	4.21e-06	197	208	8	44e49943d62bfe622b40ad0460093d31540544df
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDKN2D E2F7 ARHGAP11A MKI67 PIMREG KNL1 SHANK3 IGFBP7	4.21e-06	197	208	8	76b61e60a757e58b465569538e632d6d9953e89a
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DAPK1 UTRN DSP CEP290 CP CCDC141 AQP4 PATJ	4.21e-06	197	208	8	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NET1 DAPK1 SHROOM3 DSP AQP4 P3H2 PATJ MSLN	4.37e-06	198	208	8	1851b7f4198b42c21c934e2fbda39dbd65e2625c
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NET1 DAPK1 SHROOM3 DSP AQP4 P3H2 PATJ MSLN	4.37e-06	198	208	8	c477405b093f4e5374e57bcacf1fb204a0f7eb3b
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NET1 DSP OBSL1 CP CCDC141 P3H2 PATJ ACSL5	4.37e-06	198	208	8	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	MYCBP2 CCDC18 SLC2A10 BOD1L1 UTRN SHROOM3 CEP290 SOS1	4.37e-06	198	208	8	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA4 ARHGAP11A MKI67 KCNAB2 LCP1 CCDC141 ANTXRL TRBV16	4.53e-06	199	208	8	868ff080f72b6274a84e3ae0ddee4a32ed96472a
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Club\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MB IVL DNAH5 DSP SHC4 XDH CP ATP12A	4.53e-06	199	208	8	2b17694cffbec28a2c8f165dfcff6bab94aa0f4c
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Club\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MB IVL DNAH5 DSP SHC4 XDH CP ATP12A	4.53e-06	199	208	8	111cfd589ec6795075d8d88d7664bfb23eba5bf6
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Club-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MB IVL DNAH5 DSP SHC4 XDH CP ATP12A	4.53e-06	199	208	8	d583290a1d288b749ad17bc501c1487268c6551c
ToppCell	medial-Hematologic-Proliferating_NK/T-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CDKN2D E2F7 ARHGAP11A NCR3 MKI67 PIMREG KNL1 HASPIN	4.70e-06	200	208	8	ab1f9f99cb4a381a642a2cfb32e7f8d276c2dda4
ToppCell	mLN-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	GAK ITGA4 ADSS2 FES DNAJA1 DYNC1H1 KCNAB2 LCP1	4.70e-06	200	208	8	e3c15e0e1c2602b0cc9ab8cc50c978d265350c94
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID4B MYCBP2 ITGA4 TRIP12 BOD1L1 UTRN DYNC1H1 SP110	4.70e-06	200	208	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYCBP2 DST PTPRD COL6A3 DYNC2H1 ITIH5 IGFBP7 OSMR	4.70e-06	200	208	8	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UAP1 CPQ COL6A3 CP ITIH5 IGFBP7 DCLK1 AHNAK2	4.70e-06	200	208	8	933b5b400e48a511ba0a056be1d33d3610b5f10d
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	DAPK1 UTRN MOCOS DSP CEP290 CP AQP4 PATJ	4.70e-06	200	208	8	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm\|3m / Sample Type, Dataset, Time_group, and Cell type.	SPTB MB DYSF MYPN SRL SASH1 MYOM3 CCDC141	4.70e-06	200	208	8	538ae964db58c4acafe93f735b3e03fc08fdaac6
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ARID4B MYCBP2 BOD1L1 UTRN DYNC1H1 LCP1 SP110 MIER1	4.70e-06	200	208	8	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	medial-Hematologic-Proliferating_NK/T\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CDKN2D E2F7 ARHGAP11A NCR3 MKI67 PIMREG KNL1 HASPIN	4.70e-06	200	208	8	bfde42e00a9a6b858937de87cd19c9ed3677d954
ToppCell	medial-2-Hematologic-Proliferating_NK/T\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CDKN2D E2F7 ARHGAP11A NCR3 MKI67 PIMREG KNL1 HASPIN	4.70e-06	200	208	8	3d1895490dd262e9246eb280938239a7253451dd
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SRRM4 ITGA4 COL6A3 CP SERPINA12 ITIH5 IGFBP7	5.75e-06	146	208	7	47368f981180ca6a8c81a50f7f9430f12456f609
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ITGA4 MKI67 KNL1 MOCOS KCNAB2 LCP1 SP110	9.25e-06	157	208	7	904cd98ae85ed6459e0663f077ac462842bf12df
ToppCell	severe_COVID-19-pDC\|World / disease group, cell group and cell class (v2)	NLRP7 GAS6 ZNF521 NOMO1 P3H2 MSLN RAPGEFL1	1.00e-05	159	208	7	e1c48c4ceda116826819ff9adeed7bad6a58844d
ToppCell	severe_COVID-19-pDC\|severe_COVID-19 / disease group, cell group and cell class (v2)	NLRP7 GAS6 ZNF521 NOMO1 P3H2 MSLN RAPGEFL1	1.00e-05	159	208	7	ea5088d27e42b8850455764d53b757ea8d8f14bc
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRRM4 SPTA1 SPTB DNAJA4 HPX HEPHL1 SASH1	1.05e-05	160	208	7	56e6f4b82b5dc41c45f9d253c2db314a6f702b84
ToppCell	Basal_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	MAP7D2 DSP SHC4 CP SHROOM2 FAM171A1 IGFBP7	1.05e-05	160	208	7	b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRRM4 SPTA1 SPTB DNAJA4 HPX HEPHL1 SASH1	1.05e-05	160	208	7	bb1b966fb9e801db15e67d03e49db4609d6f935a
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADCY10 MYPN HEPHL1 UNC5D SERPINA12 GUCY2F ATP12A	1.13e-05	162	208	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDKN2D CCDC18 ITGA4 ARHGAP11A MKI67 KNL1 KCNAB2	1.49e-05	169	208	7	4db49b7eaea34e6558ee73b01e76315e99cc880b
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	CDKN2D CCDC18 ARHGAP11A MKI67 PIMREG VAV3 KNL1	1.55e-05	170	208	7	73601c873b177d5d134618d8e228c51381119f7d
ToppCell	droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALT4 E2F7 MPDZ CEP76 ARHGEF11 ITGB7 CCDC97	1.61e-05	171	208	7	e852d0e8589eecf4a2e5fea039b52a67c5d58dbd
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB MB AGXT HPX SRL DSP CCDC141	1.67e-05	172	208	7	ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SLC2A10 PHKA1 FES VAV3 ZNF407 HASPIN VPS13B	1.67e-05	172	208	7	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB MB AGXT HPX SRL DSP CCDC141	1.67e-05	172	208	7	bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 CCDC141 AQP4 P3H2 PRKG2 ARHGEF2 PATJ	1.74e-05	173	208	7	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors\|lymph-node_spleen / Manually curated celltypes from each tissue	SPTA1 MB MPDZ OBSL1 ZNF521 SHANK3 IGFBP7	1.80e-05	174	208	7	6d9bdf4d28ff8ebb66ffd1ccdd6a4fe9440a83f3
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MB MYPN SRL ADSS1 MYOT AQP4 SLC8A3	1.80e-05	174	208	7	4a6e04b4f12b87c15fa1409989cbe32c43736369
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC18 E2F7 ITGA4 ARHGAP11A MKI67 KNL1 LCP1	1.80e-05	174	208	7	7b318796728001c17b4043d2b033330c7be40c78
Disease	Malignant neoplasm of breast	TBC1D9B NET1 EFCAB13 ARHGAP11A DYSF WDR53 SLC2A10 PTPRD SLC10A6 MKI67 MTMR3 MAP7D2 BOD1L1 FTO DYNC2H1 XDH SHROOM2 SP110 SLC8A3 IGFBP7 GUCY2F P3H2 VPS13B	1.57e-06	1074	203	23	C0006142
Disease	Muscular Dystrophies, Limb-Girdle	DYSF PLEC MYOT GNE TRIM32	2.54e-06	32	203	5	C0686353
Disease	muscular dystrophy (is_implicated_in)	DYSF COL6A3 MYOT TRIM32	4.83e-06	17	203	4	DOID:9884 (is_implicated_in)
Disease	Intellectual Disability	TMEM94 KDM3B KARS1 TAOK1 TAT DYNC1H1 CNDP1 CACNA1E RARS1 XPA PREPL SLC1A4 SHANK3	1.49e-05	447	203	13	C3714756
Disease	Limb-girdle muscular dystrophy	DYSF PLEC MYOT TRIM32	2.89e-05	26	203	4	cv:C0686353
Disease	Lambert-Eaton Myasthenic Syndrome	PLEC PREPL	4.71e-05	2	203	2	C0022972
Disease	Myasthenic Syndrome	PLEC PREPL	4.71e-05	2	203	2	C0549225
Disease	Hereditary xanthinuria	MOCOS XDH	4.71e-05	2	203	2	cv:C5779508
Disease	attention function measurement	E2F7 DST PTPRD MYPN FTO TASOR P3H2	7.75e-05	148	203	7	EFO_0007636
Disease	Autosomal recessive limb-girdle muscular dystrophy	DYSF PLEC TRIM32	1.10e-04	14	203	3	cv:C2931907
Disease	arthritis	SHANK3 GAN	1.41e-04	3	203	2	EFO_0005856
Disease	sarcoma (biomarker_via_orthology)	ADSS2 ADSS1	1.41e-04	3	203	2	DOID:1115 (biomarker_via_orthology)
Disease	Bardet-Biedl syndrome 1 (disorder)	MKKS CEP290 TRIM32	2.03e-04	17	203	3	C2936862
Disease	Bardet-Biedl syndrome	MKKS CEP290 TRIM32	2.43e-04	18	203	3	cv:C0752166
Disease	age at menopause	NCR3 ADSS2 BOD1L1 CHD6 FTO MGA DYNC1H1 GSPT1 ZFHX4	2.61e-04	302	203	9	EFO_0004704
Disease	Hereditary elliptocytosis	SPTA1 SPTB	2.80e-04	4	203	2	cv:C0013902
Disease	Global developmental delay	TMEM94 KDM3B KARS1 TAOK1 CACNA1E RARS1	3.27e-04	133	203	6	C0557874
Disease	hereditary spherocytosis (is_implicated_in)	SPTA1 SPTB	4.65e-04	5	203	2	DOID:12971 (is_implicated_in)
Disease	Hereditary spherocytosis	SPTA1 SPTB	4.65e-04	5	203	2	cv:C0037889
Disease	Anemia, hereditary spherocytic hemolytic	SPTA1 SPTB	4.65e-04	5	203	2	C0221409
Disease	Peripheral Nervous System Diseases	DAPK1 MKI67 MYOT GAN	5.26e-04	54	203	4	C4721453
Disease	body fat percentage, coronary artery disease	FES FTO DYNC2H1	5.84e-04	24	203	3	EFO_0001645, EFO_0007800
Disease	response to gemcitabine	DAPK1 DOCK1 ITIH5	6.60e-04	25	203	3	GO_0036272
Disease	hydrocephalus (biomarker_via_orthology)	HSPD1 AQP4	6.94e-04	6	203	2	DOID:10908 (biomarker_via_orthology)
Disease	Elliptocytosis, Hereditary	SPTA1 SPTB	6.94e-04	6	203	2	C0013902
Disease	congenital muscular dystrophy (implicated_via_orthology)	DYNC1H1 COL6A3	6.94e-04	6	203	2	DOID:0050557 (implicated_via_orthology)
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP1A3 ATP12A	9.67e-04	7	203	2	DOID:0060178 (implicated_via_orthology)
Disease	epidermolysis bullosa simplex (is_implicated_in)	DST PLEC	9.67e-04	7	203	2	DOID:4644 (is_implicated_in)
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	DYSF FER1L5	9.67e-04	7	203	2	DOID:11724 (implicated_via_orthology)
Disease	Ciliopathies	MKKS DNAH5 DYNC2H1 CEP290 TRIM32	1.00e-03	110	203	5	C4277690
Disease	Drug habituation	ZNF606 DOCK1 BPIFA2 EHHADH PATJ	1.22e-03	115	203	5	C0013170
Disease	Drug abuse	ZNF606 DOCK1 BPIFA2 EHHADH PATJ	1.22e-03	115	203	5	C0013146
Disease	Prescription Drug Abuse	ZNF606 DOCK1 BPIFA2 EHHADH PATJ	1.22e-03	115	203	5	C4316881
Disease	Substance-Related Disorders	ZNF606 DOCK1 BPIFA2 EHHADH PATJ	1.22e-03	115	203	5	C0236969
Disease	Drug Use Disorders	ZNF606 DOCK1 BPIFA2 EHHADH PATJ	1.22e-03	115	203	5	C0013222
Disease	Drug Dependence	ZNF606 DOCK1 BPIFA2 EHHADH PATJ	1.22e-03	115	203	5	C1510472
Disease	Substance Dependence	ZNF606 DOCK1 BPIFA2 EHHADH PATJ	1.22e-03	115	203	5	C0038580
Disease	Substance Use Disorders	ZNF606 DOCK1 BPIFA2 EHHADH PATJ	1.22e-03	115	203	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	ZNF606 DOCK1 BPIFA2 EHHADH PATJ	1.22e-03	115	203	5	C0029231
Disease	Substance abuse problem	ZNF606 DOCK1 BPIFA2 EHHADH PATJ	1.27e-03	116	203	5	C0740858
Disease	Hereditary spherocytosis	SPTA1 SPTB	1.28e-03	8	203	2	C0037889
Disease	lean body mass	DIS3L2 PTPRD MTMR3 PLEC FTO TASOR SEC16B PRKG2 PATJ	1.32e-03	379	203	9	EFO_0004995
Disease	epilepsy (is_implicated_in)	CP ATP1A3	1.64e-03	9	203	2	DOID:1826 (is_implicated_in)
Disease	electroencephalogram measurement	E2F7 PTPRD SASH1 PRKG2	1.72e-03	74	203	4	EFO_0004357
Disease	body surface area	DIS3L2 E2F7 TRIP12 DOCK5 MTMR3 PLEC FTO TASOR EEF1AKMT4-ECE2 SEC16B PRKG2 PATJ	1.76e-03	643	203	12	EFO_0022196
Disease	Cardiomyopathies	MYPN HSPD1 MYOT DSP SOS1	2.10e-03	130	203	5	C0878544
Disease	PR domain zinc finger protein 1 measurement	USP4 EHHADH	2.49e-03	11	203	2	EFO_0801904
Disease	longitudinal BMI measurement	PTPRD FTO DOCK1 CACNA1E	2.50e-03	82	203	4	EFO_0005937
Disease	response to anticonvulsant	VAV3 COL6A3 SASH1 ZNF521	2.85e-03	85	203	4	GO_0036277
Disease	nervous system disease (implicated_via_orthology)	ATP1A3 ATP12A	2.97e-03	12	203	2	DOID:863 (implicated_via_orthology)
Disease	chronic kidney disease (implicated_via_orthology)	SHROOM3 XDH	2.97e-03	12	203	2	DOID:784 (implicated_via_orthology)
Disease	Dystonia	CACNA1E COL6A3 CP ATP1A3	2.97e-03	86	203	4	C0013421
Disease	myocardial infarction	FES CCDC97 COL6A3 SHROOM3 SASH1 DYNC2H1 LCP1 FGD6	3.06e-03	350	203	8	EFO_0000612
Disease	hemoglobin A1 measurement	SPTA1 SPTB GAS6 ZNF236 INTS14 MTMR3 USP4 FTO MGA RARS1	3.38e-03	520	203	10	EFO_0007629
Disease	middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement	MYCBP2 SHC4	3.49e-03	13	203	2	EFO_0006514, EFO_0010316
Disease	interleukin 13 measurement	DAPK1 NKD2 PATJ	3.68e-03	45	203	3	EFO_0008171
Disease	tetralogy of Fallot (implicated_via_orthology)	DNAH5 DOCK1	4.06e-03	14	203	2	DOID:6419 (implicated_via_orthology)
Disease	Bardet-Biedl syndrome (is_implicated_in)	MKKS TRIM32	4.06e-03	14	203	2	DOID:1935 (is_implicated_in)
Disease	chromosome-type aberration frequency	EFCAB13 FTO	4.06e-03	14	203	2	EFO_0009861
Disease	Seizures	KDM3B MPDZ KARS1 CACNA1E RARS1 SLC8A3	4.11e-03	218	203	6	C0036572
Disease	Body Weight	FTO SEC16B	4.66e-03	15	203	2	C0005910
Disease	Opioid use measurement	NLRP7 PTPRD	4.66e-03	15	203	2	EFO_0009937
Disease	Situs ambiguus	DNAH5 SHROOM3	4.66e-03	15	203	2	C0266642
Disease	Adenoid Cystic Carcinoma	ARID4B GAS6 DAPK1 MGA	5.10e-03	100	203	4	C0010606
Disease	Pre-Eclampsia	STOX1 CP	5.30e-03	16	203	2	C0032914
Disease	diabetic retinopathy (implicated_via_orthology)	ITGA4 AQP4	5.30e-03	16	203	2	DOID:8947 (implicated_via_orthology)
Disease	epilepsy (implicated_via_orthology)	DYNC1H1 CACNA1E SLC1A4 ATP1A3 ATP12A	5.51e-03	163	203	5	DOID:1826 (implicated_via_orthology)
Disease	Dystonia, Limb	COL6A3 ATP1A3	5.98e-03	17	203	2	C0751093
Disease	Dystonia, Diurnal	COL6A3 ATP1A3	5.98e-03	17	203	2	C0393610
Disease	Antithrombotic agent use measurement	FES FTO LCP1	6.47e-03	55	203	3	EFO_0009925
Disease	Ischemic stroke, fibrinogen measurement	RAPGEF6 PLEC SHANK3	6.47e-03	55	203	3	EFO_0004623, HP_0002140
Disease	Dystonia, Paroxysmal	COL6A3 ATP1A3	6.70e-03	18	203	2	C0393588
Disease	left ventricular mass	FTO CCDC141	6.70e-03	18	203	2	EFO_0009289

Protein segments in the cluster

Peptide	Gene	Start	Entry
HIKEILITAGGENVP	ACSBG2	511	Q5FVE4
PGVVHVIDVDRGEEK	AQP4	296	P55087
VQDDHIKGPLKVGAI	ARID4B	51	Q4LE39
KAIIHAINDDNVPGL	DAPK1	346	P53355
EVLEHLPGKTQDEVQ	CCDC112	191	Q8NEF3
QQDGLEKVHLEPVRI	CPQ	96	Q9Y646
NGLDQLQKIVPDGHT	ANTXRL	136	A6NF34
ELRGNHGAKEPTIQE	CACNA1E	961	Q15878
DKIGSVPGIHQLRDV	CLPX	361	O76031
LEELHLEPGVVQGLF	ARHGEF2	266	Q92974
QEGGQVLHSEEVPLL	B3GALT4	211	O96024
GKHQVLLEDPEQEGS	ARHGEF11	1141	O15085
LVAEHPGLVSKVNIG	CPA2	136	P48052
VEHVLVPGDTGVDKR	CCDC144CP	96	Q8IYA2
VEHVLAPGDTGVDKR	CCDC144NL	96	Q6NUI1
EPGDVIIVLDQKDHS	DNAJA4	236	Q8WW22
QVLGGKAFLEHLQEP	CEP76	111	Q8TAP6
TLNLEDVQPHDLGKV	HSPD1	331	P10809
DVQPHDLGKVGEVIV	HSPD1	336	P10809
HIFNLPLKGEGIEIV	ADCY10	1281	Q96PN6
KVLVEHGADVNVPDG	CDKN2D	91	P55273
DIHVPEGQEVTLGAL	CDHR5	51	Q9HBB8
PGDIIIVLDQKDHAV	DNAJA1	236	P31689
LNGDLVVVKLLPEEH	DIS3L2	106	Q8IYB7
PEKVDLGETIHGVQV	BCO2	256	Q9BYV7
EGVSPEHLEQLLGQL	CDAN1	1046	Q8IWY9
QVGKGDEVTITLPHI	EAF1	51	Q96JC9
ELGGIPIVANKINHS	ARMC10	136	Q8N2F6
LFLEGQIHPELEGVE	NOMO3	801	P69849
LEGKQIHGEQLDPHV	OSMR	181	Q99650
QGIHSENGPVLVEEL	OTUD4	306	Q01804
ENGPVLVEELGKKHT	OTUD4	311	Q01804
IGLGVSHPVLKQVAE	UQCRC2	221	P22695
KPDGTVEQIGHILVS	NET1	241	Q7Z628
VERKAEEEHLGILGP	CP	796	P00450
PLQDVEGREHGIAVL	OBSL1	346	O75147
LFLEGQIHPELEGVE	NOMO2	801	Q5JPE7
ETENGKHVSILDLPG	DTD2	71	Q96FN9
EPGAGAQEVTLKVHI	FAM171A1	26	Q5VUB5
PGGAVVDEIHSLIEK	IL18R1	421	Q13478
VEGVEHEESQKPLNG	KDM7A	626	Q6ZMT4
IPENAEGHIILGKSL	MKKS	186	Q9NPJ1
KGNLPSILDVHVNVG	TAT	11	P17735
PGDLEDDEGLKHLQQ	GIGYF1	416	O75420
NGTRLVVEKEHPQLG	NCR3	121	O14931
VVEKEHPQLGAGTVL	NCR3	126	O14931
AAGPQGEEALEKHVV	MAP7D2	351	Q96T17
VGEGPEAVLTVKGHQ	ITIH5	871	Q86UX2
QVIHPGLQEVGLKLN	MGA	721	Q8IWI9
QVEHLGTGLKELPDV	MGA	2876	Q8IWI9
GELIEVVHLPLEGAQ	NUDT14	176	O95848
DENKIGAIPEEIGHL	LRRIQ4	196	A6NIV6
GAIPEEIGHLTGLQK	LRRIQ4	201	A6NIV6
VKEVLGEHIVPSDQQ	EIF1AD	11	Q8N9N8
ETATHKDLIPLQGGE	SLC2A10	191	O95528
LLQKAEEHEESQGPV	DST	5296	Q03001
PAVLKQGEEIHNEVE	FTO	361	Q9C0B1
AVLHEVKREGLPVEQ	FTO	416	Q9C0B1
LEVVGKEGQALPIHL	KATNIP	1231	O60303
KGGPQSVIHVLADEV	PHKA1	221	P46020
GVGNEKTPIAIEIEH	ATP12A	291	P54707
GLPENEHQLSVAGKI	DCLK1	651	O15075
QQGEPDLTEHEKVAI	CCDC97	81	Q96F63
LGHVVDEIQRNEKPV	EHHADH	76	Q08426
VVHIEQGGLVKPERD	HSF1	81	Q00613
HLLEQVAPKGDEEGV	LCP1	301	P13796
IGPKGHVISQIAQEA	ERAL1	401	O75616
LFLEGQIHPELEGVE	NOMO1	801	Q15155
GHQKDPDIGDLLDQL	PI4KA	1701	P42356
EQLQAKTGLKGIPEH	KDM3B	826	Q7LBC6
PIGEGAHDEEVLKTI	KDM3B	1576	Q7LBC6
GPSELQELGKTNLEH	KNL1	801	Q8NG31
NIEDGHVLPGLIHKV	GFUS	181	Q13630
VGPVKENDEIEAGIH	FAHD1	196	Q6P587
GSQVLPVLKENVEGH	MOCOS	861	Q96EN8
EVQKLLGPHVEGLKA	MSLN	546	Q13421
VNGSVIDEPVRLKHG	MKI67	71	P46013
LAIQTRGGPEKHEVT	IGFBP7	216	Q16270
GVEALQLVDREAKPH	P3H2	196	Q8IVL5
ASGNLVPLEDVHIKG	PARP4	616	Q9UKK3
NPRHIEIQVLGDKHG	PCCA	266	P05165
SDLEPVGAGIQHLQK	PIMREG	201	Q9BSJ6
LQVALPAEKAEGREH	NKD2	66	Q969F2
PNKHNVEVLGILSDD	GSPT1	336	P15170
IKQGEPGNHIFVLAE	PRKG2	196	Q13237
IHPADAVKLGQAELV	NAT10	371	Q9H0A0
IHGGGINTLDIEPVE	ERCC8	41	Q13216
EVQLPELFHKIGVGA	KCNAB2	226	Q13303
PQEKGADHTQAIVLG	ITGB7	716	P26010
EIHQLVLVASDGGDP	PCDHGA3	206	Q9Y5H0
IPEAHQATLLDGKQG	BOD1L1	1366	Q8NFC6
PQEDGVDLLGLHSEV	GAK	876	O14976
LKPGDDVIETGQHNT	DYNC2H1	1061	Q8NCM8
KHGEEQQLPAVGLTN	EEF1AKMT4-ECE2	801	P0DPD8
VEESAGLVGLKLPHQ	FMC1	91	Q96HJ9
NVVDKLEPVLHEGLE	BPIFA2	31	Q96DR5
VEQPKELGDAHDVQI	CCDC141	811	Q6ZP82
GEKEEIVVTLLPAGH	DCLRE1C	101	Q96SD1
KDIHVNGQLPAAEEI	E2F7	651	Q96AV8
IVEGKGQHETVIPGD	DOCK1	71	Q14185
VEDLGQHETVIPGEL	DOCK5	71	Q9H7D0
VPKDEAVGALHLIQA	GNE	616	Q9Y223
IIDDQLPVDHKGELL	CAPN7	346	Q9Y6W3
VEDRSIAGIPKLEHG	LINC01599	191	Q8WXQ3
LETEPVKLGGHQVES	CCDC18	486	Q5T9S5
QTLQAGILEVHEDPG	CHD6	2306	Q8TD26
HVPEGAETEQGLKRE	CEP290	2326	O15078
LTVGGIPFHEKDLVQ	GAS6	421	Q14393
DAHLVLDGEEIPVQK	GAN	31	Q9H2C0
GGIIDPHRNEKLTVD	DSP	2056	P15924
VDKDGQVGHGLQPVE	GUCY2F	1076	P51841
HLVLPIALNKEGDEV	INTS14	271	Q96SY0
DQDIQGEISHPDGKV	CENPJ	1146	Q9HC77
PQHLVLVLGGKSQDD	COL6A3	1541	P12111
RGGEDPNQKVIHGVI	CUL2	171	Q13617
GKIGIVELAHVLPTE	CALB1	71	P05937
VEHVLAPGDTGVDKR	CCDC144B	96	Q3MJ40
LGPEAIVHIVNKADI	ACSL5	166	Q9ULC5
VEHFLKGLNELVPEN	AREL1	676	O15033
NILSHVDNGKIGIPD	EFCAB13	766	Q8IY85
VDNGKIGIPDLEHAL	EFCAB13	771	Q8IY85
KIIAIEGPDLVNGSH	HASPIN	511	Q8TF76
EAHLGILGPVIKAEV	HEPHL1	451	Q6MZM0
TEVVGGAPQHEQIGK	ITGA4	266	P13612
GLEVGKTPIAIEIEH	ATP1A3	266	P13637
RDIKPSNLLVGEDGH	CAMKK2	311	Q96RR4
GVEGVAHIIDPKAIS	DYNC1H1	2246	Q14204
PEDIEKVANGVLDIH	LAMB4	1496	A4D0S4
QATVLELQKSPHGGE	CCDC168	1946	Q8NDH2
VEHILAPGDTGVDKR	CCDC144A	96	A2RUR9
GIPLDQGSELHVVVK	DYSF	56	O75923
DVNLVVPLEVIKGDH	CMTR1	476	Q8N1G2
HKLQGSGPLVLTEEE	CREB3L2	256	Q70SY1
IPLKEQGGEVSQAHL	DNAH5	2466	Q8TE73
KEEVKVEGLHINGPT	MIER1	416	Q8N108
PAHRAGIEIQEGKED	MTMR3	706	Q13615
AELILHGQEEEKPAQ	FAM114A1	466	Q8IWE2
AVDGEDDKPHEILGI	PTPRD	651	P23468
DHVPIILVGNKADLA	REM1	186	O75628
QELLQTKLEHLGPGE	FES	381	P07332
EKEVGTPHGIILDSV	HPX	346	P02790
QPRGHLEIGEKLDII	SARS2	201	Q9NP81
IEKVEIAGPGFINVH	RARS1	151	P54136
IQSVNHIEGLTKPGE	MEIOC	556	A2RUB1
GEQIAVIHEKQPDVI	UTRN	1921	P46939
VIHEKQPDVILEASG	UTRN	1926	P46939
GQVKVPLDDLTNHDI	ARHGAP11A	956	Q6P4F7
LQEVEEGLAQHKPVL	AGXT	136	P21549
PVNLEGDDTSLIHGK	SLC6A15	666	Q9H2J7
QDVELLKVGHVGPLQ	TRIM32	276	Q13049
HRDGDVVLPAGVVVK	SNIP1	16	Q8TAD8
ILNGTVEISHPDGKV	RAPGEF6	321	Q8TEU7
GVVIHLPGLFEEAEK	ADSS1	101	Q8N142
QPGDHLTDITLKVAG	KARS1	116	Q15046
EGEGQKDVLPAHLRV	FER1L5	746	A0AVI2
LETGVHLDPAVKEVQ	CDC40	66	O60508
EHGEPLVITKIEEGS	SHROOM2	46	Q13796
LEHGEPLIISKVEEG	SHROOM3	46	Q8TF72
KPLQEVEIAAITHGA	TAOK1	121	Q7L7X3
GEERLKNPDLIQVGH	NLRP7	506	Q8WX94
SELPGGDNHIIKIEL	MYCBP2	3841	O75592
GDNHIIKIELKGPEN	MYCBP2	3846	O75592
IHLPGLFEEAEKNVQ	ADSS2	101	P30520
GQPKHLEEEEGQLKH	IVL	381	P07476
PGHGIQEKLQVVDKV	SP110	381	Q9HB58
EEGNPEVLKRHGKEL	SOS1	941	Q07889
HGKINNLIENIDPGT	SERPINA12	186	Q8IW75
NEDIAGFIHKIPGLV	TASOR	1281	Q9UK61
HLGKAPQESQVVVEG	TBC1D9B	1116	Q66K14
QVDVKLLEGHVPEGA	AHNAK2	1226	Q8IVF2
EVQAGQVDVKLPEGH	AHNAK2	2706	Q8IVF2
EVQAGQVDVKLPEGH	AHNAK2	2871	Q8IVF2
EVQAGQVDLKLPEGH	AHNAK2	3036	Q8IVF2
EVQAGQVDVKLPEGH	AHNAK2	3201	Q8IVF2
QVDVKLPEGHVLEGA	AHNAK2	3206	Q8IVF2
EVQAGQVDVKLPEGH	AHNAK2	3366	Q8IVF2
EVQAGQVDLKLPEGH	AHNAK2	4521	Q8IVF2
KHNELTGDNVGPLIL	CISD2	116	Q8N5K1
VLIPLGAVDDGEHSQ	CNDP1	466	Q96KN2
GQAKHLLLVDPEGKV	SHC4	566	Q6S5L8
KETAPLEGHQQQGDE	YBX2	256	Q9Y2T7
GKVVGETHVDPIQLQ	ZFHX4	3181	Q86UP3
VEGQQPIVRKVVEHG	USP4	111	Q13107
HAPEEQEGLLVVKVE	ZSCAN30	11	Q86W11
VQHLELPKDQGGLGI	MPDZ	1481	O75970
LPINNGSKENGIHEE	SNX1	66	Q13596
GEGEIPLHRGEAVKV	SHANK3	486	Q9BYB0
GKRIHVLPIDDTVEG	VCP	111	P55072
RGIKDDEHIVLEPGD	TMEM94	201	Q12767
IVGGKDTPLNAIVIH	PATJ	1451	Q8NI35
NVTHEKIPIGTEIEG	SLC1A4	206	P43007
GGENEVIPEVLRKSH	STOX1	611	Q6ZVD7
GQNFLEKLIGIEVPH	SRL	166	Q86TD4
LKQVHEAQDPGLIVS	ZNF521	456	Q96K83
EKLGQHLATEPLGTN	SRRM4	61	A7MD48
HEIVQPGRVFLKEGI	FGD6	1081	Q6ZV73
ENTSLQEHGVKLGPA	SASH1	1066	O94885
SEEELPVGLEVHGNL	SLC10A6	16	Q3KNW5
GENHTIFIGPVEKLI	SENP6	641	Q9GZR1
QHPDAKLVVGNTEIG	XDH	251	P47989
ILDIQPGGNHVIEDS	PREPL	681	Q4J6C6
GLIDEKHRELPEDVG	SPTB	1811	P11277
KRLEGELVAHEPAIQ	SPTA1	1756	P02549
VTDEEEHGNILPKLN	WDR53	306	Q7Z5U6
EHGNILPKLNIEHGE	WDR53	311	Q7Z5U6
KAGVVGPELHEQLLS	PLEC	3551	Q15149
VDEAVRKGLVGPELH	PLEC	3881	Q15149
DERHQGGQLLEEPKL	UNC5D	726	Q6UXZ4
PLIIDENGVHELVKN	UAP1	506	Q16222
LGPENLHGEQKIEAE	USP20	896	Q9Y2K6
RQLEQKVAGDIGDPH	SEC16B	706	Q96JE7
GKVEADIPGHGQEVL	MB	16	P02144
EEEEQKIGKVVHQPG	XPA	81	P23025
VHQGKAGIKILEPEE	ZBTB17	636	Q13105
TKVHPGGTVNQILDE	VPS13B	2921	Q7Z7G8
LHIFQPEGKIGNQVE	ZNF28	151	P17035
DLEPQHVVGTEEAGL	ZNF236	821	Q9UL36
AKDVLIQLPGQEVSH	ZNF407	2016	Q9C0G0
QGLLQEEEGAGHIIK	RAPGEFL1	231	Q9UHV5
KGGKDIPVTIHNLEE	TRIP12	1806	Q14669
EEVAQTPKHLVRGEG	TRBV16	21	A0A087WV62
GNSLEKVDPQLVDGH	PTGR2	111	Q8N8N7
GHLLSVGNQIAKPEV	ZNF606	96	Q8WXB4
PQGDGEIRITTLDKH	VAV3	401	Q9UKW4
RGIIIETEGDHPKGI	SLC8A3	271	P57103
ANPGELVLDHIVERK	MUS81	321	Q96NY9
LEDKPGAHEIEVGVD	MYOM3	896	Q5VTT5
PDHEIQGSKEALIQD	MYOT	146	Q9UBF9
GKELENSPDIHIVQA	MYPN	306	Q86TC9